GC Biopharma Corp. (KRX:006280)
135,000
+1,800 (1.35%)
Nov 17, 2026, 3:30 PM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.54 trillion as of November 16, 2026. It is the 9,026th most valuable company in the world and the 215th biggest in South Korea. Its market cap has decreased by 3.16% in one year.
Market Cap
1.54T
Enterprise Value
2.52T
Revenue
1.96T
Global Rank
Country Rank
#215 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.54T, an increase of 5,197.34%. That is a compound annual growth rate of 13.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 1.54T | -15.09% |
| Dec 30, 2025 | 1.81T | -11.42% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 5.81T |
| Hanall Biopharma | 2.63T |
| Celltrion Pharm | 1.82T |
| Daewoong Pharmaceutical | 1.17T |
| Chong Kun Dang Pharmaceutical | 815.60B |
| Boryung | 735.26B |
| Daewoong | 690.25B |
| Dong-A Pharmaceutical | 607.03B |